Alfred Lumsdaine Acquires 10,000 Shares of Ardent Health (NYSE:ARDT) Stock

Ardent Health, Inc. (NYSE:ARDT) CFO Alfred Lumsdaine purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the purchase, the chief financial officer directly owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Ardent Health Stock Performance

Ardent Health stock opened at $9.39 on Wednesday. Ardent Health, Inc. has a 12-month low of $7.71 and a 12-month high of $15.48. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of 9.88, a price-to-earnings-growth ratio of 1.97 and a beta of 0.84. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. The firm’s fifty day moving average price is $9.41 and its 200 day moving average price is $9.11.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, research analysts forecast that Ardent Health, Inc. will post 1.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ARDT. UBS Group lifted their price target on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Royal Bank Of Canada dropped their price target on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, March 9th. Leerink Partners dropped their price target on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Finally, Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $14.21.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company boosted its stake in Ardent Health by 3.7% during the 1st quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock valued at $255,000 after purchasing an additional 1,072 shares during the period. Geode Capital Management LLC boosted its stake in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period. Caitong International Asset Management Co. Ltd boosted its stake in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after purchasing an additional 2,638 shares during the period. Alliancebernstein L.P. boosted its stake in Ardent Health by 24.8% during the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock valued at $218,000 after purchasing an additional 3,272 shares during the period. Finally, New York State Common Retirement Fund boosted its stake in Ardent Health by 121.4% during the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the period.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.